Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127398171 | 12739817 | 1 | I | 20160811 | 20160908 | 20160913 | 20160913 | EXP | DE-JNJFOC-20160907383 | JANSSEN | 0.00 | DY | M | Y | 2.21000 | KG | 20160913 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127398171 | 12739817 | 1 | PS | RISPERIDON | RISPERIDONE | 1 | Transplacental | U | U | 20272 | 3 | MG | UNSPECIFIED | ||||||
127398171 | 12739817 | 2 | SS | DULOXETINE. | DULOXETINE | 1 | Transplacental | U | 0 | 30 | MG | UNSPECIFIED | QD | ||||||
127398171 | 12739817 | 3 | SS | AKINETON | BIPERIDEN HYDROCHLORIDE | 1 | Transplacental | U | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127398171 | 12739817 | 1 | Bipolar disorder |
127398171 | 12739817 | 2 | Bipolar disorder |
127398171 | 12739817 | 3 | Extrapyramidal disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127398171 | 12739817 | HO |
127398171 | 12739817 | OT |
127398171 | 12739817 | CA |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127398171 | 12739817 | Foetal exposure during pregnancy | |
127398171 | 12739817 | Gastroschisis | |
127398171 | 12739817 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |